In a recent study of breast cancer patients, 35% of 306 HER2-overexpressing tumours were found to express EGFR Conversely, 87% of EGFR-overexpressing tumours were found to overexpress HER2 as well (DiGiovanna et al, 2005). This evidence concerns the gene ERBB2 and neoplasm.